Descriptions

Sox11 acts as a transcriptional activator of TEAD2 by binding to its gene promoter. This protein possesses intrinsically disordered regions (IDRs) with large negative charge, some of which involve a consecutive sequence of aspartate (D) or glutamate (E) residues, known as D/E repeats. These D/E repeats can cause autoinhibition through intramolecular electrostatic interaction with HMG boxes and modulate binding to DNA. This autoinhibited state can transition into the uninhibited complex with DNA through an electrostatically driven induced-fit process, which accelerates the target DNA search kinetics in the presence of non-functional high-affinity ligands ('decoys').

Autoinhibitory domains (AIDs)

Target domain

82-173 (HMG box domain)

Relief mechanism

Assay

Accessory elements

No accessory elements

References

Autoinhibited structure

Activated structure

1 structures for Q8T3B9

Entry ID Method Resolution Chain Position Source
AF-Q8T3B9-F1 Predicted AlphaFoldDB

No variants for Q8T3B9

Variant ID(s) Position Change Description Diseaes Association Provenance
No variants for Q8T3B9

No associated diseases with Q8T3B9

1 regional properties for Q8T3B9

Type Name Position InterPro Accession
domain High mobility group box domain 92 - 162 IPR009071

Functions

Description
EC Number
Subcellular Localization
  • Nucleus
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

1 GO annotations of cellular component

Name Definition
nucleus A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.

3 GO annotations of molecular function

Name Definition
DNA binding Any molecular function by which a gene product interacts selectively and non-covalently with DNA (deoxyribonucleic acid).
DNA-binding transcription activator activity, RNA polymerase II-specific A DNA-binding transcription factor activity that activates or increases transcription of specific gene sets transcribed by RNA polymerase II.
RNA polymerase II cis-regulatory region sequence-specific DNA binding Binding to a specific upstream regulatory DNA sequence (transcription factor recognition sequence or binding site) located in cis relative to the transcription start site (i.e., on the same strand of DNA) of a gene transcribed by RNA polymerase II.

9 GO annotations of biological process

Name Definition
mesodermal cell fate specification The cell fate determination process in which a cell becomes capable of differentiating autonomously into a mesoderm cell in an environment that is neutral with respect to the developmental pathway; upon specification, the cell fate can be reversed.
myoblast fate specification The process in which a cell becomes capable of differentiating autonomously into a myoblast in an environment that is neutral with respect to the developmental pathway. Upon specification, the cell fate can be reversed. A myoblast is a mononucleate cell type that, by fusion with other myoblasts, gives rise to the myotubes that eventually develop into skeletal muscle fibers.
neuron differentiation The process in which a relatively unspecialized cell acquires specialized features of a neuron.
positive regulation of egg-laying behavior Any process that activates or increases the frequency, rate or extent of oviposition.
positive regulation of embryonic development Any process that activates or increases the frequency, rate or extent of embryonic development.
positive regulation of mesodermal cell fate specification Any process that activates or increases the frequency, rate or extent of mesoderm cell fate specification.
positive regulation of post-embryonic development Any process that activates or increases the frequency, rate or extent of post-embryonic development. Post-embryonic development is defined as the process whose specific outcome is the progression of the organism over time, from the completion of embryonic development to the mature structure.
positive regulation of transcription by RNA polymerase II Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
positive regulation of vulval development Any process that activates or increases the frequency, rate or extent of development of the vulva. Vulval development is the process whose specific outcome is the progression of the egg-laying organ of female and hermaphrodite nematodes over time, from its formation to the mature structure. In nematodes, the vulva is formed from ventral epidermal cells during larval stages to give rise to a fully formed vulva in the adult.

15 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
P48435 SOX11 Transcription factor SOX-11 Gallus gallus (Chicken) SS
P48436 SOX9 Transcription factor SOX-9 Homo sapiens (Human) PR
O94993 SOX30 Transcription factor SOX-30 Homo sapiens (Human) PR
O15370 SOX12 Transcription factor SOX-12 Homo sapiens (Human) SS
P35716 SOX11 Transcription factor SOX-11 Homo sapiens (Human) EV
Q04888 Sox10 Transcription factor SOX-10 Mus musculus (Mouse) PR
Q04886 Sox8 Transcription factor SOX-8 Mus musculus (Mouse) SS
Q04887 Sox9 Transcription factor SOX-9 Mus musculus (Mouse) PR
Q04890 Sox12 Transcription factor SOX-12 Mus musculus (Mouse) SS
Q05738 Sry Sex-determining region Y protein Mus musculus (Mouse) SS
Q7M6Y2 Sox11 Transcription factor SOX-11 Mus musculus (Mouse) SS
P0C1G9 Sox11 Transcription factor SOX-11 Rattus norvegicus (Rat) SS
Q6GLH8 sox17b.2 Transcription factor Sox-17-beta.2 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) PR
Q66JF1 sox11 Transcription factor Sox-11 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) SS
Q8AWH2 sox17b.1 Transcription factor Sox-17-beta.1 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) PR
10 20 30 40 50 60
MDLQKPPNFM LDCGMAPHMM PPINWAAAAI AVASSTSGAT NATSSNSVAT SQQLQHHPYG
70 80 90 100 110 120
TAAGGYKHAQ QAIPKSVTPY SDATNCKKSS NHIKRPMNAF MVWSQMERRK ICEHQPDMHN
130 140 150 160 170 180
AEISKQLGSR WRSLTDEEKA PFVAEAERLR VCHMQEYPDY KYKPRKKPKK NPDGTLQQPA
190 200 210 220 230 240
QPQAPQQQQA PPRGASPQAR QRKRPNTDQQ SETQQFQNFK SVKVEQDWMG NAHMSHAQKM
250 260 270 280 290 300
PFHPSYPSPS EFGHAPLTPE SGFYDDYFTQ QHHQQHFASQ HHNSAGSPLR MTNLGMDMGM
310 320 330 340 350 360
PPQMMGHNSG FGAGNHPFYL HTSPPSVDQD DMRSLSSGSS GYADCSASEQ STSSPNSAGV
370 380 390 400
VTMATAATTT THLDDLEQIC PTVTTGELVN YPWSDALGID INFS